Screener
Ionis Pharmaceuticals IONS Unrealized Gains on Investments
Unrealized Gains on Investments at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| June 30, 2026 | Amortized / Cost | Gross Unrealized / Gains | Gross Unrealized / Losses | Estimated / Fair Value |
|---|---|---|---|---|
| Debt securities issued by the U.S. Treasury | 181,168 | - | (1,340) | 179,828 |
| Debt securities issued by states of the U.S. and political subdivisions of the states | 731 | - | (1) | 730 |
| Total debt securities with a maturity of more than one year | 651,145 | 91 | (3,911) | 647,325 |
| Total available-for-sale debt securities | $$1,788,862 | $516 | $(5,012) | 1,784,366 |
| Equity securities: | ||||
| Publicly traded equity securities included in other current assets (2) | $$11,897 | $45,670 | $(9,799) | 47,768 |
| Privately held equity securities included in deposits and other assets (3) | 10,000 | 9,816 | - | 19,816 |
| Total equity securities | 21,897 | 55,486 | (9,799) | 67,584 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's unrealized gains on investments?
- Ionis Pharmaceuticals (IONS) reported unrealized gains on investments of $516K in Q2 2026.
- How has Ionis Pharmaceuticals's unrealized gains on investments changed year-over-year?
- Ionis Pharmaceuticals's unrealized gains on investments decreased by 79.4% year-over-year, from $2.51M to $516K.
- What is the long-term trend for Ionis Pharmaceuticals's unrealized gains on investments?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's unrealized gains on investments has grown at a 35.2% compound annual growth rate (CAGR), from $1.26M to $4.22M.
- What does unrealized gains on investments mean?
- This reflects the cumulative positive difference between the current fair market value and the carrying value of available-for-sale debt securities. These gains are typically recorded in accumulated other comprehensive income rather than the income statement. It indicates the potential upside value embedded within the company's treasury investment portfolio.
Ask your AI about Ionis Pharmaceuticals's unrealized gains on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude